Publication

NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma

Abstract
No abstract available
Citation
Agarwal G, Kazeroun M, Salazar M, McBean K, Kannan A, Larham J, Varghese S, Balik B, Browning J, Caulier A, Chan YLT, Giles H, Jenner M, Kishore B, Pratt G, Rabin N, Robinson R, Talbot A, van de Wyngaert Z, Xu K, Moore S, Boyle E, Ansari-Pour N, Ramasamy K, Hamblin A, Thakurta A, Gooding S. NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma. Br J Haematol. 2025 Nov;207(5):2167-2172. doi: 10.1111/bjh.70111. Epub 2025 Aug 26.
Journal / Source Title
British Journal of Haematology
DOI
10.1111/bjh.70111
PMID
41251385
Publisher
Wiley-Blackwell
Publisher’s URL
https://onlinelibrary.wiley.com/journal/13652141
Publisher’s statement
Note / Copyright